Pociute, A. (2024). High-Grade Serous Ovarian Cancer Drug Development: Investigating the mechanism of action of PLK1 and BRD4 inhibitors in HGSOC. Swansea, Wales, UK.
Chicago Style CitationPociute, Agne. High-Grade Serous Ovarian Cancer Drug Development: Investigating the Mechanism of Action of PLK1 and BRD4 Inhibitors in HGSOC. Swansea, Wales, UK, 2024.
MLA CitationPociute, Agne. High-Grade Serous Ovarian Cancer Drug Development: Investigating the Mechanism of Action of PLK1 and BRD4 Inhibitors in HGSOC. Swansea, Wales, UK, 2024.
Warning: These citations may not always be 100% accurate.